Cardiac autonomic dysfunction is associated with high-risk albumin-to-creatinine ratio in young adolescents with type 1 diabetes in adDIT (Adolescent Type 1 diabetes cardio-renal interventional trial)

Diabetes Care

Volumn 38, Issue 4, 2015, Pages 676-681

  Cho, Yoon Hi ^a,b   Craig, Maria E ^a,b,c   Davis, Elizabeth A ^d,e   Cotterill, Andrew M ^f   Couper, Jennifer J ^g   Cameron, Fergus J ^h,i,j   Benitez Aguirre, Paul Z ^a,b   Dalton, R Neil ^k   Dunger, David B ^l   Jones, Timothy W ^d,e   Donaghue, Kim C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f MATER CHILDREN S HOSPITAL   (Australia)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁱ MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k ST THOMAS HOSPITAL   (United Kingdom)

^l ADDENBROOKE S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ALBUMINOID; CREATININE;

ADOLESCENT; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIAC AUTONOMIC DYSFUNCTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MALE; MICROALBUMINURIA; RISK FACTOR; URINALYSIS; AUTONOMIC NERVOUS SYSTEM; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; DIABETIC NEPHROPATHIES; ELECTROCARDIOGRAPHY; HEART; HEART RATE; INNERVATION; METABOLISM; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ALBUMINS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART RATE; HUMANS; MALE; RISK FACTORS;

EID: 84942786356     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1848     Document Type: Article

References (38)

1. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-1579.
2. Pfeifer MA, Weinberg CR, Cook DL, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 1984;7: 447-453.
3. Weinrauch LA, Kennedy FP, Gleason RE, Keough J, D'Elia JA. Relationship between autonomic function and progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure control. Am J Hypertens 1998;11:302-308.
4. Clarke CF, Eason M, Reilly A, Boyce D, Werther GA. Autonomic nerve function in adolescents with type 1 diabetes mellitus: relationship to microalbuminuria. Diabet Med 1999;16: 550-554.
5. Mølgaard H, Christensen PD, Sørensen KE, Christensen CK, Mogensen CE. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992;41:812-817.
6. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 1994;17: 578-584.
7. Malpas SC, Maling TJ. Heart-rate variability and cardiac autonomic function in diabetes. Diabetes 1990;39:1177-1181.
8. Weston PJ, Panerai RB, McCullough A, et al. Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index. Diabetologia 1996;39: 1385-1391.
9. Jaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care 2013;36:157-162.
10. Cho YH, Craig ME, Srinivasan S, et al. Heart rate variability in pubertal girls with type 1 diabetes: its relationship with glycaemic control, insulin resistance and hyperandrogenism. Clin Endocrinol (Oxf) 2014;80:818-824.
11. Dunger DB, Schwarze CP, Cooper JD, et al. Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet Med 2007;24:531-136.
12. Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group. Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatr 2009;9:79.
13. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996;17: 354-381.
14. Marcovecchio ML, Woodside J, Jones T, et al.; AdDIT Investigators. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments. Diabetes Care 2014; 37:805-813.
15. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992;11:1305-1319.
16. Report of the Second Task Force on Blood Pressure Control in Childrend1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79:1-25.
17. Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE. High normo- or low microalbuminuria: basis for intervention in insulindependent diabetes mellitus. Kidney Int Suppl 1997;63:S15-S18.
18. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998;41:416-423.
19. Martini G, Riva P, Rabbia F, et al. Heart rate variability in childhood obesity. Clin Auton Res 2001;11:87-91.
20. Lafferty AR, Werther GA, Clarke CF. Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care 2000;23:533- 538.
21. Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB. Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes 1992;41: 1035-1041.
22. Daniels M, DuBose SN, Maahs DM, et al.; T1D Exchange Clinic Network. Factors associated with microalbuminuria in 7, 549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry. Diabetes Care 2013;36:2639-2645.
23. Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB; Oxford Regional Prospective Study Group. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Diabetes Care 2001;24:555-560.
24. Marcovecchio ML, Dalton RN, Schwarze CP, et al. Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria inyoung people with type 1 diabetes. Diabetologia 2009;52:1173-1181.
25. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002;347:797-805.
26. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 1995;26:808-814.
27. Winocour PH, Dhar H, Anderson DC. The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics. Diabet Med 1986;3: 436-440.
28. Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993;16:773-779.
29. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006;29: 334-339.
30. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004;43:699-706.
31. Tahrani AA, Dubb K, Raymond NT, et al. Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: A cohort study. Diabetologia 2014;57:1249- 1256.
32. Jerums G, MacIsaac RJ. Diabetes: Predicting renal function decline in patients with T2DM. Nat Rev Endocrinol 2014;10:381-382.
33. Maguire AM, Craig ME, Craighead A, et al. Autonomic nerve testing predicts the development of complications: A 12-year follow-up study. Diabetes Care 2007;30:77-82.
34. Mottl AK, Lauer A, Dabelea D, et al.; SEARCH for Diabetes in Youth Study Group. Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes. Diabetes Care 2013;36: 3633-3638.
35. Bjornstad P, Snell-Bergeon JK, Rewers M, et al. Early diabetic nephropathy: A complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care 2013;36:3678-3683.
36. Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig 2013; 4:4-18.
37. Cherney DZ, Scholey JW, Sochett E, Bradley TJ, Reich HN. The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: A pilot study. Diabetes Care 2011;34:177-180.
38. Lanza GA, Pitocco D, Navarese EP, et al. Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J 2007;28:814-820.